OACCU
Oaktree Acquisition Corp. III Life Sciences
NASDAQ · Financial Services · Asset Management · US
$10.89
−1.00%Institutional positioning
13F filings over the trailing two quarters
New 1Increased 0Reduced 3Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ADAR1 Capital Management, LLC | Unchanged | 516,482 | Aug 14, 2026 |
| ADAR1 Capital Management, LLC | Reduced | 516,482 | May 18, 2026 |
| Affinity Asset Advisors, LLC | Unchanged | 250,000 | Aug 13, 2026 |
| AFFINITY ASSET ADVISORS, LLC | Unchanged | 250,000 | May 14, 2026 |
| ATHOS CAPITAL LTD | Unchanged | 50,000 | May 13, 2026 |
| Athos Capital Ltd | Unchanged | 50,000 | Aug 13, 2026 |
| DLD ASSET MANAGEMENT, LP | New Position | 44,519 | May 13, 2026 |
| Clear Street Group Inc. | Unchanged | 22,221 | May 15, 2026 |
| Clear Street Group Inc. | Reduced | 21,975 | Aug 12, 2026 |
| UBS GROUP AG | Unchanged | 9,765 | May 5, 2026 |
| UBS Group AG | Reduced | 9,464 | Aug 13, 2026 |
| DLD Asset Management, LP | Sold Out | 0 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings